ProteanTecs key facts
as of Oct 2026- Developer of an analytics platform designed to increase the performance and reliability of electronic systems.
- ProteanTecs is valued at approximately $449.6M as of Oct 2026 (last reported valuation).
- It has raised $241.5M; the latest was Later Stage VC ($51.0M) in Mar 2026.
- Notable investors include Mitsubishi UFJ Capital, Valor Equity Partners, Intel Capital, Avenir Growth Capital, Addition — 26 tracked in total.
- Status: Privately Held (backing).
ProteanTecs's last reported valuation, May 2022. Nothing priced has surfaced since.
- ·The complete investor list: 26 names
- ·Watch ProteanTecs: the Monday email on marks, rounds and moves
ProteanTecs funding rounds
No funding rounds for ProteanTecs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs ProteanTecs
26+ProteanTecs valuation
ProteanTecs's last reported valuation was $450 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.
ProteanTecs investors
26 investors are on record for ProteanTecs, including Mitsubishi UFJ Capital, Valor Equity Partners, Intel Capital and Avenir Growth Capital. By type, the record holds 12 venture capital firms, 2 growth equity firms and 1 hedge fund.
About ProteanTecs
Developer of an analytics platform designed to increase the performance and reliability of electronic systems. The company's cloud-based platform combines data created in chip-embedded agents with machine learning, enabling manufacturers to increase the performance and quality, making electronics more predictable, safer, and reliable for customers.
- Sector
- Information Technology
- HQ
- Haifa, Israel
- Founded
- 2017
- Employees
- 200
- Website
- proteantecs.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.